Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance)

BACKGROUND: Despite targeted antiemetics, data support an unmet need related to the management of delayed nausea and vomiting (NV). Promising pilot data informed this phase III trial evaluating gabapentin for delayed NV from highly emetogenic chemotherapy (HEC). METHODS: Participants were randomized...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Cancer
Κύριοι συγγραφείς: Barton, Debra L., Thanarajasingam, Gita, Sloan, Jeff A., Diekmann, Brent, Fuloria, Jyotsna, Kottschade, Lisa A., Lyss, Alan P., Jaslowski, Anthony J., Mazurczak, Miroslaw A., Blair, Scott C., Terstriep, Shelby, Loprinzi, Charles L.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2014
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221473/
https://ncbi.nlm.nih.gov/pubmed/25043153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28892
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια